Closed System Transfer Devices Global Market to Generate $1.78 Billion By 2028, Registering at a CAGR of 14.3% | Cardinal Health Inc., ICU Medical Inc., Equashield LLC, Hospira Inc., Nipro Corporation

"The new report published by The Business Research Company, titled ""Closed System Transfer Devices Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the closed system transfer devices market size has grown rapidly in recent years. It will grow from $0.91 billion in 2023 to $1.04 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The closed system transfer devices market size is expected to see rapid growth in the next few years. It will grow to $1.78 billion in 2028 at a compound annual growth rate (CAGR) of 14.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Rising Cancer Incidence Fueling Growth in the Closed System Transfer Devices Market
The increasing occurrence of cancer is expected to propel the growth of the closed-system transfer devices market going forward. Cancer is a disease characterized by an uncontrolled division of abnormal cells, which can invade nearby tissues and spread to other body parts through the blood and lymph systems. The cases of cancer are on the rise due to various factors, such as lifestyle factors, environmental exposures, and increased infections. Closed-system transfer devices are essential tools in cancer treatment, protecting healthcare workers and patients from the risks associated with handling and administering chemotherapy drugs. Their use contributes to a safer healthcare environment and better treatment outcomes for cancer patients. For instance, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with many deaths. Furthermore, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, there were 1,958,310 new cancer cases in the United States and 609,820 cancer deaths are projected to occur in 2023. Therefore, increasing cancer cases drive the closed system transfer devices market.

Innovations In Closed System Transfer Devices Advancing Safety And Efficacy In Drug Handling
Major companies operating in the closed-system transfer devices market are developing innovative closed-system transfer devices. Next-generation closed system transfer devices represent a proactive approach to addressing the evolving needs and challenges associated with the safe handling and administration of hazardous drugs in healthcare settings. For instance, in December 2021, B. Braun Medical Inc., a US-based company that manufactures healthcare devices, launched the next-generation OnGuard 2 Closed System Transfer Device (CSTD). The OnGuard 2 CSTD was tested explicitly with actual hazardous drugs for vapor containment, making it a market leader in CSTD air-cleaning technology. This advanced CSTD incorporates enhanced features to ensure easy operation, integration into healthcare practices, and compliance with USP quality standards for handling hazardous drugs.

The closed system transfer devices market covered in this report is segmented -
1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based , Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers , Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15767&type=discount

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company , Baxter International Inc. , Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd. , Vygon SA , Codan Medical GmbH, Equashield LLC , Hospira Inc., Nipro Corporation , Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical , Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Contents of the report:
1. Executive Summary
2. Closed System Transfer Devices Market Report Structure
3. Closed System Transfer Devices Market Trends And Strategies
4. Closed System Transfer Devices Market - Macro Economic Scenario
5. Closed System Transfer Devices Market Size And Growth
…..
27. Closed System Transfer Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.